IL6 and metabolic syndrome: Inflammation is believed to be a driver of metabolic syndrome [6], with the condition displaying enhanced secretion of pro-inflammatory cytokines (e.g., interleukin-6; IL-6, and tumour necrosis factor α; TNFα) from adipose tissue and leukocytes [7].